ARCA BIOPHARMA INC (ABIO)

US00211Y5069 - Common Stock

2.4  -0.1 (-4%)

After market: 2.48 +0.08 (+3.33%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-6-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
9.13M7.30M10.60M19.34M9.77M
Research and Development
664.00K1.01M4.75M13.83M4.99M
Selling, General, and Administrative Expenses
8.47M6.28M5.85M5.50M4.77M
Operating Income
-9.13M-7.30M-10.60M-19.34M-9.77M
Interest Income/Expense
1.93M1.96M675.00K13.00K20.00K
Other Income/Expense
N/A0.00-5.00KN/AN/A
Income Before Taxes
-7.20M-5.34M-9.93M-19.32M-9.75M
Income Tax
N/AN/AN/A0.00-10.00K
Net Income
-7.20M-5.34M-9.93M-19.32M-9.74M
EBITDA
-9.12M-7.28M-10.58M-19.32M-9.76M
 
Per Share Data
EPS Diluted Total Ops
-0.50-0.37-0.69-1.39-2.07
Non GAAP EPS
N/AN/AN/AN/A-2.50
 
Statistics

All data in USD

Charts